Nebenwirkungen · Lokelma
Lokelma 5 g powder for oral suspension Lokelma 10 g powder for oral suspension · Abschnitt 4.8 · PDF-Seite 6
HOS-133817 · Präparat HOS-097504
The adverse reactions identified from controlled trials and post-marketing reports are shown in Table 1. Adverse reactions listed below are classified according to frequency and system organ class (SOC). The following convention was used for frequency of adverse reactions: Very common (≥ 1/10); Common (≥ 1/100 to < 1/10); Uncommon (≥ 1/1 000 to < 1/100); Rare (≥ 1/10 000 to < 1/1 000); Very rare (< 1/10 000); not known (cannot be estimated from the available data).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-09-02T16:15:00Z · SHA-256 9a57e63114421578bcab7ac6769b720be4b42c5e469c19bbe95a69fe93e5ab56 · Passage 46fa92334029ceef5a1632b01280a8c1443dc80ceab3986361251b4840b00a91 · Zeichen 1604–2073 im Abschnitt